Evangelos S. Gragoudas
#130,378
Most Influential Person Now
Evangelos S. Gragoudas's AcademicInfluence.com Rankings
Evangelos S. Gragoudasmedical Degrees
Medical
#2161
World Rank
#2565
Historical Rank
Ophthalmology
#37
World Rank
#53
Historical Rank
Download Badge
Medical
Evangelos S. Gragoudas's Degrees
- Doctorate Medicine Harvard University
Why Is Evangelos S. Gragoudas Influential?
(Suggest an Edit or Addition)Evangelos S. Gragoudas's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pegaptanib for neovascular age-related macular degeneration. (2004) (2145)
- Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration (1994) (1278)
- Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. (1994) (908)
- VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (2004) (657)
- Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. (1996) (626)
- Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. (2002) (593)
- Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. (1996) (514)
- Epidemiologic aspects of uveal melanoma. (1988) (511)
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. (2001) (500)
- VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization (2003) (426)
- PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION (2002) (387)
- Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. (1999) (387)
- Diffusion of high molecular weight compounds through sclera. (2000) (367)
- Survival of patients with metastases from uveal melanoma. (1991) (366)
- Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. (1996) (316)
- Adverse Reactions due to Indocyanine Green (1994) (313)
- Adverse reactions due to indocyanine green. (1994) (262)
- Vascular targeting in photodynamic occlusion of subretinal vessels. (1994) (251)
- Ocular blood flow velocity in age-related macular degeneration. (1995) (244)
- Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families (2012) (235)
- Long-term results of proton beam irradiated uveal melanomas. (1987) (214)
- A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. (2000) (212)
- Proton beam irradiation. An alternative to enucleation for intraocular melanomas. (1980) (209)
- Experience with nontreatment of central serous choroidopathy. (1974) (205)
- Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. (1996) (202)
- Transscleral delivery of bioactive protein to the choroid and retina. (2000) (201)
- Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. (1999) (197)
- Monochromatic ophthalmoscopy and fundus photography. The normal fundus. (1977) (187)
- Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. (1998) (187)
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. (2014) (183)
- Host factors, UV radiation, and risk of uveal melanoma. A case-control study. (1990) (181)
- Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres. (2003) (170)
- Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. (2002) (169)
- Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. (2002) (166)
- Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. (1999) (161)
- Increased scleral rigidity and age-related macular degeneration. (1989) (147)
- Relative survival rates after alternative therapies for uveal melanoma. (1990) (145)
- Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. (1997) (142)
- Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study. (1982) (141)
- Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples (1998) (140)
- Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. (1985) (140)
- Preliminary Report on Effects of Photocoagulation Therapy. (2018) (138)
- Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. (1999) (136)
- Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. (2003) (132)
- Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. (1996) (131)
- Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. (1994) (129)
- Clinical characteristics of choroidal neovascular membranes. (1987) (128)
- Proton irradiation of small choroidal malignant melanomas. (1977) (127)
- Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. (2002) (127)
- A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. (2000) (126)
- Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. (1999) (123)
- Clinical course of macular holes: the Eye Disease Case-Control Study. (1999) (123)
- Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. (1990) (122)
- Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. (1995) (120)
- Photodynamic Therapy of Experimental Choroidal Neovascularization Using Lipoprotein-Delivered Benzoporphyrin (1995) (119)
- Radiation maculopathy after proton beam irradiation for choroidal melanoma. (1992) (117)
- Relative biological effectiveness of modulated proton beams in various murine tissues. (1984) (116)
- Intraocular recurrence of uveal melanoma after proton beam irradiation. (1992) (110)
- Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment (2016) (110)
- Visual outcome after proton beam irradiation of uveal melanoma. (1986) (108)
- The risk of enucleation after proton beam irradiation of uveal melanoma. (1989) (104)
- Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. (2005) (102)
- Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. (2006) (102)
- Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. (1987) (101)
- Current results of proton beam irradiation of uveal melanomas. (1982) (98)
- Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations. (2014) (97)
- The expanded clinical spectrum of deferoxamine retinopathy. (2002) (97)
- Histologic correlation of in vivo optical coherence tomography images of the human retina. (2006) (96)
- Retinal manifestations of neurofibromatosis. Diagnosis and management. (1991) (95)
- Treatment of metastatic tumors of the choroid with proton beam irradiation. (2005) (93)
- In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography. (2011) (88)
- Inhibition of Hsp90 attenuates inflammation in endotoxin‐induced uveitis (2007) (86)
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report (2004) (84)
- Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration (2005) (84)
- Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. (1988) (83)
- Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. (2002) (82)
- Metastasis from uveal melanoma after proton beam irradiation. (1988) (81)
- Natural history of disciform degeneration of the macula. (1974) (81)
- Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. (1987) (80)
- Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. (1985) (79)
- Uveal melanoma: proton beam irradiation. (2005) (79)
- Conservative treatment of uveal melanoma: local recurrence after proton beam therapy. (1989) (79)
- Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates. (1998) (77)
- Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. (1997) (76)
- Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. (2009) (75)
- Prognosis for rubeosis iridis following central retinal vein occlusion. (1979) (74)
- Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas. (1982) (73)
- Lens changes after proton beam irradiation for uveal melanoma. (1995) (72)
- Endogenous endostatin inhibits choroidal neovascularization (2007) (70)
- Conservative treatment of uveal melanoma: probability of eye retention after proton treatment. (1988) (70)
- Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma (2018) (70)
- Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. (2004) (69)
- Patterns of tumor initiation in choroidal melanoma. (2000) (69)
- Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. (2002) (67)
- Germline brca2 sequence variants in patients with ocular melanoma (1999) (65)
- Histopathology of proton beam-irradiated vs enucleated uveal melanomas. (1992) (64)
- Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. (1997) (64)
- Endothelial cell loss in irradiated optic nerves. (2000) (63)
- Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. (1986) (61)
- Ciliary body and choroidal melanomas treated by proton beam irradiation. Histopathologic study of eyes. (1983) (61)
- Proton therapy at Harvard. (1985) (61)
- Verteporfin inhibits growth of human glioma in vitro without light activation (2017) (60)
- Familial uveal melanoma. (1994) (59)
- Vascular adhesion protein‐1 blockade suppresses choroidal neovascularization (2008) (59)
- Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. (2000) (58)
- Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. (2006) (58)
- Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. (2008) (57)
- Talc emboli and macular ischemia in intravenous drug abuse. (1979) (57)
- Evaluation of the clinical applicability of proton beams in definitive fractionated radiation therapy. (1982) (57)
- Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine. (1989) (55)
- Proton beam irradiation for neovascular age-related macular degeneration. (2006) (54)
- Inhibition of vascular adhesion protein‐1 suppresses endotoxin‐induced uveitis (2008) (54)
- Disciform degeneration of the macula. II. Pathogenesis. (1976) (52)
- Abnormal scleral findings in uveal effusion syndrome. (1988) (52)
- Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma. (1989) (51)
- Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. (1996) (51)
- Monochromatic ophthalmoscopy and fundus photography. II. The pathological fundus. (1979) (50)
- Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity (2017) (50)
- Occupation and risk of uveal melanoma. An exploratory study (1992) (50)
- Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization. (2000) (50)
- Cataract extraction after proton beam irradiation for malignant melanoma of the eye. (1992) (49)
- Iris color as a prognostic factor in ocular melanoma. (1999) (49)
- Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. (2010) (48)
- Proton beam irradiation and hyperthermia. Effects on experimental choroidal melanoma. (1985) (47)
- High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. (2012) (47)
- Neodymium yttrium aluminum garnet laser surgery on experimental vitreous membranes (1984) (47)
- Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. (2009) (46)
- Clinical experience and expectation with protons and heavy ions. (1977) (46)
- Cancer-Associated Retinopathy: Update on Pathogenesis and Therapy (2011) (46)
- Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma. (2001) (45)
- Increased efficacy of radiation therapy by use of proton beam. (1990) (45)
- Correlation of epinephrine use and macular edema in aphakic glaucomatous eyes. (1978) (45)
- Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis (2013) (45)
- Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma. (2016) (45)
- Expression of leukocyte adhesion molecules in human subfoveal choroidal neovascular membranes treated with and without photodynamic therapy. (2004) (43)
- A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma. (2000) (43)
- Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. (2010) (43)
- The time course of irradiation changes in proton beam-treated uveal melanomas. (1993) (42)
- Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy. (2015) (42)
- Case-control study of idiopathic retinal detachment. (1990) (42)
- Long-term observations of proton-irradiated monkey eyes. (1979) (42)
- Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas (2017) (40)
- Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. (1996) (39)
- ESTABLISHMENT OF PIGMENTED CHOROIDAL MELANOMAS IN A RABBIT MODEL (1994) (39)
- Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. (1989) (39)
- Proton-beam irradiated epithelioid cell melanoma of the ciliary body. (1981) (39)
- RETINAL VASCULITIS IN POLYARTERITIS NODOSA (1986) (39)
- Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration (2018) (39)
- Pathologic examination of ciliary body melanoma treated with proton beam irradiation. (1985) (39)
- Childbearing history associated with improved survival in choroidal melanoma. (1999) (38)
- An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization. (2005) (38)
- A computerized image analysis method for measuring elastic tissue. (1989) (38)
- BILATERAL MELANOCYTIC UVEAL TUMORS ASSOCIATED WITH SYSTEMIC NON‐OCULAR MALIGNANCY: Malignant Melanomas or Benign Paraneoplastic Syndrome? (1987) (36)
- Proton irradiation for peripapillary and parapapillary melanomas. (2011) (36)
- Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form. (1997) (36)
- Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP‐dependent kinase (2010) (36)
- Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors. (1996) (36)
- An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma (1997) (36)
- Intraocular pressure in diabetes. Relationship to retinopathy and blood glucose level. (1971) (35)
- Occupation and Risk of Uveal Melanoma (1992) (34)
- Advances in Treatment of Retinal Angiomas (1997) (34)
- Prognostic factor study of survival after enucleation for juxtapapillary melanomas. (1985) (34)
- Constitutional alterations in p16 in patients with uveal melanoma (1996) (34)
- Regression patterns of uveal melanomas after proton beam irradiation. (1982) (34)
- Photodynamic therapy of pigmented choroidal melanomas. (1995) (33)
- Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. (2008) (32)
- Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. (1997) (31)
- Multiple choroidal metastasis from bronchial carcinoid treated with photocoagulation and proton beam irradiation. (1979) (31)
- Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells. (2000) (31)
- Proton Beam Irradiation Using a Light-Field Technique for the Treatment of Choroidal Hemangiomas (2006) (30)
- Preliminary results of proton beam irradiation of macular and paramacular melanomas. (1984) (30)
- Utilizing Targeted Gene Therapy with Nanoparticles Binding Alpha v Beta 3 for Imaging and Treating Choroidal Neovascularization (2011) (30)
- VLA‐4 blockade suppresses endotoxin‐induced uveitis: in vivo evidence for functional integrin up‐regulation (2007) (30)
- Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. (2004) (29)
- Choroidal metastases from renal cell carcinoma. (1997) (29)
- Serum zinc and serum lipid profiles in 778 adults. (1995) (28)
- The Subretinal Fibrosis and Uveitis Syndrome (1996) (28)
- RHEGMATOGENOUS RETINAL DETACHMENT IN EYES WITH UVEAL MELANOMA (1996) (28)
- Clinical Ocular Oncology (1990) (28)
- CONSERVATION TREATMENT OF THE EYE: CONFORMAL PROTON REIRRADIATION FOR RECURRENT UVEAL MELANOMA (2001) (27)
- An evaluation of the influence of reproductive factors on the risk of metastases from uveal melanoma. (1993) (27)
- Small unilateral foveal hemorrhages in young adults. (1980) (27)
- Proton irradiation of malignant melanoma of the ciliary body. (1979) (26)
- Peripapillary subretinal neovascularization in presumed sarcoidosis. (1981) (26)
- Systematic genomic and translational efficiency studies of uveal melanoma (2017) (26)
- Evaluation of skin microtopography as a measure of ultraviolet exposure. (1992) (26)
- Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. (2006) (25)
- Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing (2017) (24)
- Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model. (2006) (23)
- Proton beam therapy for age-related macular degeneration: development of a standard plan. (1999) (22)
- Branch retinal artery occlusion associated with recurrent toxoplasmic retinochoroiditis. (1987) (22)
- Neodymium-YAG laser surgery on experimental vitreous membranes. (1984) (22)
- Systemic antiangiogenic therapy for choroidal neovascularization. What is the role of interferon alfa? (1992) (22)
- Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization. (2007) (21)
- The Bragg Peak of Proton Beams for Treatment of Uveal Melanoma (1980) (21)
- Effects of metformin on retinoblastoma growth in vitro and in vivo (2014) (21)
- Examination of the ocular fundus with monochromatic light. (1976) (21)
- Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma. (2003) (21)
- Enhanced depth imaging spectral-domain optical coherence tomography findings in sclerochoroidal calcification. (2012) (20)
- Interobserver and intraobserver reliability in the clinical classification of drusen. (1988) (20)
- Evidence for vasculitis in acute posterior multifocal placoid pigment epitheliopathy. (1979) (19)
- Traumatic anterior ischemic optic neuropathy. (1981) (19)
- POSTERIOR UVEAL MELANOMA IN YOUNG PATIENTS TREATED WITH PROTON BEAM THERAPY (2010) (19)
- Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study. (2019) (19)
- MRI of Blood Volume and Cellular Uptake of Superparamagnetic Iron in an Animal Model of Choroidal Melanoma (2002) (19)
- Uveal Metastases (1997) (19)
- Management of uveal melanoma: A continuing dilemma (1993) (19)
- Blindness as a consequence of a paraneoplastic syndrome in a woman with clear cell carcinoma of the ovary. (1999) (18)
- Smoking and the risk of early metastases from uveal melanoma. (1992) (18)
- Von Hippel's disease in association with von Recklinghausen's neurofibromatosis. (1978) (18)
- VLA–4 Blockade Attenuates Leukocyte Accumulation in the Retinal Vessels of Streptozotocin–Induced Diabetic Rats (2006) (18)
- CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH MALIGNANT MELANOMA: (1982) (18)
- Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma. (1996) (18)
- Peripapillary subretinal neovascularization and serous macular detachment. Association with congenital optic nerve pits. (1984) (17)
- Mortality after diagnosis of small melanocytic lesions of the choroid. (2010) (17)
- Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model. (2007) (17)
- Limited choroidal hemorrhage mistaken for a choroidal melanoma. (1987) (17)
- In vivo sodium chemical shift imaging (1992) (16)
- Long-term results after proton irradiation of uveal melanomas (1997) (16)
- Neovascularization of the optic disk associated with atypical retinitis pigmentosa. (1985) (16)
- Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. (2008) (16)
- Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea. (2016) (16)
- Proton and sodium 23 magnetic resonance imaging of human ocular tissues. A model study. (1987) (16)
- Magnetic resonance imaging: An emerging technique for the diagnosis of ocular disorders (1990) (16)
- Peripheral retinal neovascularization in sarcoidosis and sickle cell anemia. (1977) (16)
- A novel nonradioactive method to evaluate vascular barrier breakdown and leakage. (2010) (16)
- [Photodynamic therapy of pigmented choroidal melanomas in rabbits]. (2002) (15)
- Clinical experience with proton beam radiation therapy. (1980) (15)
- Comparison of transillumination and histologic slide measurements of tumor diameter in uveal melanoma. (1988) (15)
- In vivo imaging of endothelial injury in choriocapillaris during endotoxin‐induced uveitis (2007) (14)
- VEGF Inhibition Study in Ocular Neovascularization–1 (VISION–1): Efficacy Results From Phase II/III MacugenTM (Pegaptanib Sodium) Clinical Trials (2004) (14)
- 1996 Jules Gonin Lecture of the Retina Research Foundation (1997) (14)
- LOCALIZATION OF ROSE BENGAL, ALUMINUM PHTHALOCYANINE TETRASULFONATE, AND CHLORIN e6 IN THE RABBIT EYE (2002) (14)
- Photoimmunotherapy of human uveal melanoma cells. (1995) (14)
- The effects of pre-enucleation irradiation on the development of metastases from intraocular Greene melanoma in hamsters. (1985) (13)
- Ocular Melanocytoma (2009) (13)
- Outcomes of proton therapy for the treatment of uveal metastases. (2013) (13)
- Preliminary results of photodynamic therapy for choroidal neovascularization in pathologic myopia. ocular histoplasmosis syndrome and idiopathic causes within a phase i/ii study (1997) (12)
- High-grade uveal B-cell lymphoma as the initial feature in Richter syndrome. (2002) (12)
- Treatment of experimental choroidal melanoma with an Nd:yttrium-lanthanum-fluoride laser at 1047 nm. (2003) (12)
- Color Doppler Imaging of Untreated and Irradiated Choroidal Melanomas (2001) (12)
- Standardized data collection and coding in eye disease epidemiology: the Uveal Melanoma Data System. (1991) (12)
- Unusual Hemorrhagic Lesions Masquerading as Choroidal Melanoma (1997) (12)
- Melanocytoma of the optic nerve associated with sound-induced phosphenes. (2006) (12)
- Digital angiography of experimental choroidal melanomas using benzoporphyrin derivative. (1997) (11)
- [Selective occlusion of subretinal neovascularization with photodynamic therapy]. (1994) (11)
- ESTABLISHMENT OF A RABBIT MODEL OF EXTRASCLERAL EXTENSION OF OCULAR MELANOMA (1998) (11)
- MRI of blood volume with superparamagnetic iron in choroidal melanoma treated with thermotherapy. (2004) (11)
- Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin (2021) (11)
- Uveal melanoma: a rare malignancy. (2000) (10)
- Choroidal Metastases From EML4-ALK-Positive Non-Small-Cell Lung Adenocarcinoma. (2015) (10)
- Magnetic resonance imaging determination of 23Na visibility and T2∗ in the vitreous body (1989) (10)
- Immunohistochemical investigations of adult intraocular medulloepitheliomas (2015) (10)
- Proton beam therapy of uveal melanomas. (1986) (10)
- Safety and Efficacy of Intravitreal Injection of rhuFab VEGF in Combination With Verteporfin PDT on Experimental Choroidal Neovascularization (2002) (10)
- MACUIAR UVEAL MELANOMA TREATED WITH PROTON BEAM IRRADIATION: 10‐year Follow‐Up Observation with Histopathologic Correlation (1994) (10)
- Chapter 39 – Charged-Particle Irradiation of Uveal Melanoma (2006) (10)
- Checkpoint inhibitor-induced sarcoid choroidal granulomas (2020) (10)
- Magnetic resonance imaging and spectroscopy of intraocular tumors. (1989) (9)
- Bilateral Malignant Choroidal Melanomas (1980) (9)
- Digital indocyanine-green videoangiography of intraocular tumors. (1993) (9)
- MRI of blood volume with MS 325 in experimental choroidal melanoma. (2002) (9)
- Potential for low-LET charged-particle radiation therapy in cancer. (1985) (9)
- Echographic and histologic tumor height measurements in uveal melanoma. (1986) (9)
- Role of 4 Integrin ( CD 49 d ) in the Pathogenesis of Diabetic Retinopathy (2009) (9)
- Current treatment of metastatic choroidal tumors. (1989) (9)
- Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase. (2014) (8)
- Photodynamic Therapy of Choroidal Melanoma (1997) (8)
- Diagnosis of Choroidal Melanoma (2021) (8)
- Indocyanine Green Videoangiography (2008) (8)
- Treatment of rhegmatogenous retinal detachment secondary to proliferative diabetic retinopathy. (1976) (8)
- Laser photocoagulation treatment of central serous chorioretinopathy. (1994) (8)
- A- and B- Mode Ultrasound Biometry in the Proton Beam Irradiation of Uveal Melanomas (1983) (8)
- Effects of ApoE Deficiency, Aging and High Fat Diet on Laser-Induced Choroidal Neovascularization and Bruch's Membrane-RPE Interface Morphology (2007) (7)
- Non-Invasive Tonometry in the Mouse (2003) (7)
- Photosensitizers in Photodynamic Therapy of Choroidal Neovascularization (2004) (7)
- Photodynamic therapy of ocular diseases (2004) (7)
- Evaluation of choroidal lesions with swept-source optical coherence tomography (2018) (7)
- Uveal melanoma presenting after cataract extraction with intraocular lens implantation. (1985) (7)
- A feasibility study of 23Na magnetic resonance imaging of human and rabbit vitreal disorders. (1993) (7)
- Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. (2001) (6)
- Enucleation vs cobalt 60 irradiation of melanomas. (1986) (6)
- Uveal melanoma management. (1989) (6)
- Flow cytometry analysis of peripheral blood lymphocytes in patients with choroidal melanoma. (1997) (6)
- Eye-sparing treatment of massive extrascleral extension of choroidal melanoma. (1998) (6)
- Long term effect of Photodynamic Therapy (PDT) using liposomal Benzoporphyrin Derivative (BPD ) on experimental Choroidal Neovascularization (CNV) and normal retina and choroid (1996) (6)
- Proton Beam Irradiation for Treatment of Experimental Human Retinoblastoma (1991) (5)
- Photodynamic therapy of subfoveal choroidal neovascularization using benzoporphyrin derivative: First results of a multi-center trial (1996) (5)
- Proton beam irradiation for non-AMD CNV: 2-year results of a randomised clinical trial (2014) (5)
- Safety and effectiveness of magnetic resonance imaging of choroidal melanoma patients with episcleral tantalum rings after proton beam irradiation. (1988) (5)
- Genetic Risk Factors for Radiation Vasculopathy. (2018) (5)
- Preliminary results on phosphorus-31 nuclear magnetic resonance evaluation of human uveal melanoma in enucleated eyes. (1988) (5)
- Conservative treatment of uveal melanoma: survival, local control, eye retention, and vision in patients with intermediate and large tumors after proton beam therapy (1994) (5)
- Intrascleral foreign body simulating extrascleral extension of uveal melanoma. (1994) (4)
- Response of choroidal leiomyoma to treatment with proton beam radiation. (2010) (4)
- Current Approaches in the Management of Uveal Melanomas (1992) (4)
- Pupil sparing excision of an atypical iris melanocytoma induces remission of secondary glaucoma (2004) (4)
- [Photodynamic therapy of experimental, intraocular tumors with benzoporphyrin-lipoprotein]. (1994) (4)
- Conservative management of suspicious melanocytic lesions of the iris (2017) (4)
- Severe vision loss with optic disc neovascularization after hemiretinal vascular obstruction associated with optic disc melanocytoma. (2015) (4)
- Peripapillary subretinal neovascularization in chronic uveitis. (1978) (4)
- Choroidal metastases. Case 2: lung cancer. (1999) (3)
- Serpiginous Choroiditis (1996) (3)
- Radiation therapy for neovascular age-related macular degeneration revisited (2009) (3)
- Argon laser treatment in supine position. (1977) (3)
- Biopsy of an Anterior Episcleral Nodule as an Aid in Managing a Ciliary Body Melanocytic Tumor (2013) (3)
- Age-Related Macular Degeneration: Choroidal Neovascularization (2008) (3)
- Selected angiographic findings following photodynamic therapy of subfoveal choroidal neovascularization using BPD (1996) (3)
- Experimental transient exudative retinal detachment in the rat. (1994) (3)
- Basic and Clinical Aspects of Malignant Melanoma (1990) (3)
- Dynamic sodium chemical shift imaging for the study of aqueous humor flow. (1991) (3)
- Photodynamic therapy (PDT) retreatment of normal retina and choroid in the primate (1997) (3)
- Radiotherapy of ocular melanomas: precision high dose external beam proton therapy (1980) (3)
- Aggressive Skull Base Metastasis from Uveal Melanoma: A Clinicopathologic Study (2014) (3)
- Chlamydia pneumoniae is identified in human choroidal neovascular membranes secondary to age–related macular degeneration and induces vascular endothelial growth factor in vitro (2004) (2)
- Enhanced Photodynamic Therapy using Angiostatin with Verteporfin PDT in a Laser-injury Rat Model (2003) (2)
- Chapter 146 – Charged-Particle Irradiation of Uveal Melanoma (2013) (2)
- Proton Beam Irradiation of Uveal Melanomas: An Alternative of Enucleation (1983) (2)
- A systematic comparison of dose distributions delivered in iodine-125 plaque brachytherapy and proton radiation therapy for ocular melanoma. (2022) (2)
- Evaluation of Tissue Interactions with Mechanical Elements of a Transscleral Drug Delivery Device (2012) (2)
- Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field) (2020) (2)
- Uveal Malignant Melanoma – Management Options: Proton Beam Radiotherapy (2014) (2)
- Selective Targeting of Verteporfin to Choroidal Neovascularization Mediated by a Homing Peptide to VEGF-R2 (2002) (2)
- Management of Choroidal Melanomas (1986) (2)
- Non-responders to ranibizumab Anti-VEGF treatment are actually short-term responders: A prospective SD-OCT study (2020) (2)
- Transscleral Delivery of an Anti-VEGF Aptamer in a Rabbit Model (2003) (2)
- Brief Definitive Report 483 VEGF 164-mediated Inflammation Is Required for Pathological , but Not Physiological , Ischemia-induced Retinal Neovascularization (2017) (2)
- Light source for monochromatic ophthalmoscopy and fluorescein angiography. (1979) (2)
- Radiotherapie mit Protonen (1987) (1)
- Erratum: Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase (The FASEB Journal (2010) 24 (2620-2630) DOI:10.1096/fj.09-152546) (2012) (1)
- Conservative treatment of uveal melanoma with proton beam therapy: eye retention, vision, and survival after treatment (1987) (1)
- Pigment Epithelium–derived Factor, Angiopoietin–1 and VEGF Expression in human Choroidal Neovascular Membranes treated with Photodynamic Therapy. (2004) (1)
- Head and Neck (1988) (1)
- A comparison of treatment outcomes in patients receiving standard dose vs. reduced dose proton radiation for uveal melanoma (2018) (1)
- Modified Verteporfin Photodynamic Therapy (PDT), PDT Combined With Angiostatin In Vitro and In Vivo (2002) (1)
- Anti-VEGF Non-Responders are often short-term responders (2019) (1)
- Long-Term Follow-Up of Treated Patients with Choroidal Metastasis from Bronchial-Carcinoid Tumors (1993) (1)
- Complications of cataract extraction (2002) (1)
- CHAPTER 42 – Uveal malignant melanoma: management options – proton beam radiotherapy (2007) (1)
- A Spectral-domain Optical Coherence Tomography Study In Laser-induced Choroidal Neovascularization Model (2011) (1)
- TIMP3 Inhibits Vascular Leakage and Leukostasis in an Animal Model of Streptozotocin-Induced Diabetes (2007) (1)
- LONG-TERM OBSERVATION OF MULTIFOCAL METASTATIC INTRAOCULAR CARCINOID WITH ACQUIRED IRIS HETEROCHROMIA. (2017) (1)
- Pulsatile Transscleral Drug Delivery (2002) (1)
- Traumatic Choroidal Rupture: Visual Outcome and Treatment of Choroidalneovascular Membranes (2002) (1)
- Detection of Chlamydia pneumoniae in Choroidal Neovascular Membranes Isolated from Patients with Age-related Macular Degeneration (2003) (1)
- Book Review Age-Related Macular Degeneration: Principles and Practice Edited by G. Robert Hampton and Philip T. Nelsen. 300 pp., illustrated. New York, Raven Press, 1992. $80. 0-88167-916-X (1993) (1)
- An NMR blood test for uveal melanoma? (1990) (1)
- Survival in proton irradiated uveal melanoma patients: Implications for prospective randomized trials (1986) (1)
- Identification of Necroptosis as a Mechanism of Photoreceptor Damage After Retinal Detachment and Nec-1 as a Potential Treatment (2009) (1)
- Increased Laser–Induced Choroidal Neovascularization in Mice Lacking Collagen XVIII/Endostatin (2006) (1)
- Dye-enhanced laser photocoagulation of the eye (1984) (1)
- PROGRESS IN AGE-RELATED MACULAR DEGENERATION: (2006) (1)
- Modulation of Apoptosis Following Combination PEDF and Photodynamic Therapy for Choroidal Neovascularization in the Rat Model (2004) (1)
- 96142537 Risk factors for central retinal vein occlusion (1996) (1)
- CHRONICALLY PROGRESSIVE SARCOID GRANULOMA IN AN ASYMPTOMATIC PATIENT (2017) (1)
- NEW ANTIANGIOGENIC THERAPIES FOR AGE-RELATED MACULAR DEGENERATION (2006) (1)
- Retinitis pigmentosa and retinal neovascularization. (1987) (1)
- Patterns of Tumor Initiation in Choroidal Melanoma 1 (2000) (1)
- Photocoagulation treatment of pigmented intraocular tumors. (1999) (1)
- Choroidal metastasis from olfactory neuroblastoma (esthesioneuroblastoma). (1999) (1)
- Choroidal Hemangiomas (2021) (0)
- Epidemiological Study of Extremely Discordant Sibpairs with Neovascular Age-related Macular Degeneration (2003) (0)
- Serum Concentrations of Interleukin-6 and Metastasis From Uveal Melanoma (2008) (0)
- Aprotinin Reduces Intraocular Inflammation in Endotoxin Induced Uveitis (2009) (0)
- Robert Haimovici, MD (1961-2002) (2003) (0)
- Contact and immersion ultrasonography in the evaluation of topography of uveal melanomas (1987) (0)
- Evaluation of Choroidal Nevi with Swept-Source Optical Coherence Tomography (2017) (0)
- Anti–FasL Neutralizing Antibody Increases the Efficacy of PDT and Reduces the Apoptotic Damage in a Rat Laser Model (2005) (0)
- Charged Particle Irradiation of Uveal Melanomas (2021) (0)
- Management of Choroidal and Ciliary-Body Melanomas (1993) (0)
- Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma--Reply. (2016) (0)
- Verteporfin inhibits growth of human glioma in vitro without light activation (2017) (0)
- Angptl4 Suppresses TNF- Stimulated Monocyte Adhesion to Endothelial Cells by Modulation of NFB Signaling (2008) (0)
- Geldanamycin treatment reduces the inflammatory changes in the LPS–induced uveitis rat model (2004) (0)
- Uveal Melanoma: Proton Beam Radiation Therapy (2019) (0)
- A Novel Model for the Study of the Outer Blood-Retinal Barrier (2007) (0)
- Encapsulation of Anti-ICAM-1 Antibodies into PLA-PEG Microspheres: In vitro and in vivo Characterization (2003) (0)
- Choroidal Metastasis (2021) (0)
- Ocular Melanoma Induces Secretion of Anti–Tumoral Cytokines and Is Associated With Serum Levels of VEGF and TGFß (2005) (0)
- Angiopoietin-Like Protein 4 Suppresses Inflammation in Endotoxin-Induced Uveitis (2009) (0)
- Destruction of experimental choroidal melanoma: effects of trans–scleral Nd:YLF laser at 1047 nm vs. PDT using Visudyne (2004) (0)
- Book ReviewRetinal Diseases: Pathogenesis, laser therapy, and surgery (1985) (0)
- Biodistribution of the photosensitizer BPD in the tumor-bearing rabbit eye using fluorescence photometry and angiography (1996) (0)
- Retina Genetic Risk Factors for Radiation Vasculopathy (2018) (0)
- TRIBUTE TO JERRY A. SHIELDS, MD TRIBUTE (2018) (0)
- Absence of Interferon–Alfa–2a Antibodies in Patients Treated With Adjunctive IFN Therapy After Proton Beam Irradiation for Uveal Melanoma (2006) (0)
- Characterization of the Role of Apoptosis Inducing Factor (AIF) in Retina Under Normal Conditions and Retinal Detachment (2007) (0)
- Extremely Discordant Sibpair Study of the Neovascular Form of Age-Related Macular Degeneration (2002) (0)
- Enhanced Age-Related Corneal Angiogenesis in Apolipoprotein E-Deficient Mice (2007) (0)
- Reply. (2021) (0)
- The Role of AMP-Dependent Kinase a1 Isoform (AMPKa1) in Retinopathy of Prematurity (2010) (0)
- Dose–Dependant Effect of Pitavastatin on Fluorescein Angiography Leakage and VEGF Expression in a Mouse Model of Choroidal Neovascularisation (2005) (0)
- Verteporfin Without Photodynamic Therapy: Effect of the Photosensitizer on Ocular Cell Lines (2014) (0)
- Metformin affects the growth and redox state of human retinobastoma cells (2013) (0)
- Verteporfin inhibits growth of human ocular glioma in vitro without light activation (2016) (0)
- Charged particle radiotherapy for ocular melanoma (2014) (0)
- Long-term Risk ofMelanoma-RelatedMortality for Patients With Uveal Melanoma TreatedWith Proton Beam Therapy (2015) (0)
- Deferoxamine inhibits the growth of uveal melanoma cells in vitro (2015) (0)
- INVESTIGATING THE EFFECT OF CILIARY BODY PHOTODYANMIC THERAPY IN MICE (2004) (0)
- Autoperfused Micro Flow Chamber Reveals Functional Upregulation of VLA–4 on Circulating Leukocytes During Endotoxin–Induced Uveitis (2006) (0)
- Introduction: Intraocular Tumors (1993) (0)
- Radiation induced optic neuropathy. Clinical presentation and treatment (2011) (0)
- Destruction of Pigmented Choroidal Melanoma Using Trans-scleral PDT (2003) (0)
- Impact of IL-1β on Transepithelial Electrical Resistance on Rodent RPE/Choroid Explants (2008) (0)
- Regulation of Matrix Metalloproteinase 2 by AMP-Dependent Kinase (2009) (0)
- Verteporfin (VP) inhibits human retinoblastoma cell growth in vitro without light activation. (2014) (0)
- A comparison of treatment outcomes in patients receiving standard dose (70 Gy) vs reduced dose (50 Gy) proton radiation for uveal melanoma. (2022) (0)
- The Role of AMP-Dependent Kinase (AMPK) in Retinopathy of Prematurity (2009) (0)
- The Role of Sunlight in Progression of Ocular Melanoma (2007) (0)
- Receptor Interacting Protein 1 Kinase is an Essential Mediator of Programmed Photoreceptor Necrosis After Retinal Detachment (2010) (0)
- In Vivo Transscleral Delivery of FITC-Conjugated Molecules to the Rabbit Choroid and Retina (2003) (0)
- Analysis of Vascular Changes after Proton Irradiation using OCT-A in Patients with Uveal Melanoma (2019) (0)
- Inhibition of Nitric Oxide Synthetase Reduces Photoreceptor Damage Caused by Photodynamic Therapy in a Model of Choroidal Neovascularization (2006) (0)
- P-selectin Glycoprotein Ligand-1 Blockade Suppresses Endotoxin Induced Uveitis (2007) (0)
- Book ReviewRetinal Diseases (1986) (0)
- Inhibition of Very Late Antigen–4 (VLA–4) Prevents Endotoxin–Induced Uveitis (2004) (0)
- Association Between Chlamydial Heat Shock Protein 60 and Age–related Macular Degeneration (2005) (0)
- Mullerian Inhibiting Substance Inhibits the Growth of Ocular and Metastatic Uveal Melanoma Cells (2007) (0)
- Proton Beam Irradiation for Choroidal Neovascularization: Long-term Prevalence of Radiation Retinopathy (2012) (0)
- Progressive Reduction in Reading Rate in Eyes With Geographic Atrophy From Amd and Moderate Visual Loss at Baseline (2010) (0)
- Longer Follow-up Periods for Treatment of Uveal Melanoma-Reply (1982) (0)
- [Combined hyperthermia and proton irradiation: a new method in the treatment of malignant melanoma of the choroid?]. (1986) (0)
- Macular perfusion status in eyes with choroidal melanoma treated with prophylactic ranibizumab after proton beam irradiation (2018) (0)
- Aicar Inhibits the Growth of Uveal Melanoma Cells via an Amp- Kinase Independent Pathway (2009) (0)
- Retinal Detachment in a 40-Year-Old Man With Sturge-Weber Syndrome. (2021) (0)
- Photodynamic therapy for the treatment of eye diseases (2001) (0)
- Geldanamycin Treatment Reduces Choroidal Neovascularization In A Murine Model (2006) (0)
- Introducing Joan W. Miller, the 2015 Recipient of the Weisenfeld Award. (2016) (0)
- Treatment of Experimental Choroidal Melanoma with a Nd:YLF Laser at 1047 nm (2002) (0)
- Expression of Vascular Adhesion Protein-1 in Ocular Tissues of Endotoxin-Induced Uveitis (2007) (0)
- AICAR, An Exercise Mimetic, Inhibits The Growth Of Retinoblastoma In Vivo (2011) (0)
- Blood Retina Barrier Function and Angiogenesis in Apolipoprotein E Deficient Mice (2005) (0)
- Blockade of Vascular Adhesion Protein-1 Suppresses Endotoxin Induced Uveitis (2007) (0)
- In Reply to Elmali and Yazici. (2023) (0)
- The Effect of Sample Medication Use on Subsequent Anti-VEGF Agent Selection for Neovascular Age-Related Macular Degeneration (2021) (0)
- Low‐dose proton radiotherapy for pediatric choroidal hemangioma: A case series (2022) (0)
- Verteporfin-induced formation of protein oligomers is mediated by light and leads to cell toxicity. (2017) (0)
- Critical Role of Apoptosis Inducing Factor (AIF) in Photoreceptor Apoptosis in Retinal Detachment (2006) (0)
- The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma (2023) (0)
- Apoptosis Detection in Human Choroidal Neovascular Membranes Treated With Photodynamic Therapy (2005) (0)
- Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration (2018) (0)
- Apoptosis in Acute Photodynamic Therapy of Choroidal Neovascularization in the Rat Model (2003) (0)
- Characterization of Azurocidin as a Permeability Factor in the Retina:Involvement in the Leukocyte–Mediated and VEGF–Induced Blood Retina Barrier Breakdown (2006) (0)
This paper list is powered by the following services:
